Dare Bioscience: Trust proposes sale of 859 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dare Bioscience, Inc. (DARE) is the issuer for a proposed sale of 859 common shares for the account of Rastetter Family Trust. The notice lists Director as the relationship to the issuer and is signed by William H. Rastetter, trustee. It gives an approximate sale date of November 19, 2026 and an aggregate market value of $382.26.
Key Figures
Key Terms
Aggregate Market Value financial
Pre-IPO financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.